INTRODUCTION {#sec1-1}
============

Inflammatory bowel disease (IBD) included ulcerative colitis (UC), Crohn\'s disease (CD) and indeterminate colitis. They are chronic inflammatory disorders that cause inflammation in the gastrointestinal tract and their etiology, and pathogenesis is not clearly understood.\[[@ref1][@ref2][@ref3]\]

Age, race and geographical areas were reported to be associated with IBD in some epidemiological studies; however, the ultimate causes of IBD have not yet been recognized.\[[@ref4][@ref5]\] It is suggested that nutritional factors and dietary intake can be considered as significant etiological factors for both CD and UC.\[[@ref6]\]

In patients with IBD, malnutrition is usually a common problem and weight loss is reported in ≈ 75% of hospitalized patients with IBD.\[[@ref7][@ref8]\] Duration, activity and geographical extent of the disease effect on the pattern and severity of malnutrition. Although the prevalence of malnutrition is high among hospitalized IBD patients, the prevalence of malnutrition in patients with UC is lower than in CD patients.\[[@ref9][@ref10][@ref11]\] However, in these patients during periods of active disease, nutritional deficiencies can develop very fast. Therefore, nutritional care includes treatment or prevention of malnutrition and micronutrient deficiencies are important in the treatment of patients with IBD.\[[@ref2][@ref12]\]

IBD disease, especially CD, is associated with malnutrition. Duration of IBD disease, type of IBD (CD or UD) and involvement of small intestine may affect the form of malnutrition.\[[@ref13]\] Studies showed that from 20% up to 85% of the patients with IBD suffer from malnutrition. Patients with CD, generally, develop protein-energy malnutrition and those with UD develop protein malnutrition.\[[@ref14]\] Although multiple nutrient deficiencies are common in IBD, a large number of these deficiencies, aside from iron, folate and B12 deficiencies, which cause clinical manifestations, do not have clear clinical manifestations. However, many of these micronutrients are involved in bone density, thrombophilia, and carcinogenesis impact.\[[@ref15]\] Folic acid deficiency has been observed and reported in half of the patients with IBD.\[[@ref16]\] In the study of Ripoli *et al*., patients were followed up for 10 years at three-month intervals\[[@ref17]\] and there was a significant decrease in BMI, protein, lipid, calcium (CA), iron and phosphorus (P) in studied groups. Unhospitalized patients developing UC had better nutritional status than those hospitalized and the nutritional status worsened during inflammation and disease activity.\[[@ref18]\] In Jerome *et al*. studies, there has been no significant difference in regard to macronutrient reception between control and placebo group, but the level of beta-carotene, vitamins B1, B6, C and Magnesium (Mg) was lower.\[[@ref19]\]

Few studies assess the nutritional status of UC patients in Iran. Therefore, the present study aimed to investigate the nutritional status of UC patients in Isfahan, Iran.

MATERIALS AND METHODS {#sec1-2}
=====================

In this descriptive analytical cross-sectional study, between Dec 2011 and Jun 2012, 99 patients with UC who referred to Clinic of Gastroenterology in AL Zahra Hospital in Isfahan, Iran were enrolled. Patients were considered to have UC based on a typical clinical presentation of ≥4 weeks and one of either surgical, standard clinical endoscopic or radiologic changes consistent with chronic UC. Patients between 14 and 80 years old with duration of disease more than 3 months were eligible, if they had no history of any other systemic disorders including diabetes mellitus, hyperthyroidism, chronic liver and renal disease, and no history of cancer. Also patients on vitamin B12, folic acid and oral multivitamin supplements, were excluded from the study. After participating patients were explained and informed of the purposes of the study; written informed consent was obtained from them all and the protocol for this study was considered and approved in Isfahan University of Medical Sciences.

Data collection included age, sex, and duration of disease, BMI and laboratory parameters which recorded for all patients. Laboratory parameters were measured from patients' blood samples as follow: Serum albumin, serum iron, hemoglobin (Hb), folic acid, A, B12, D and E vitamins, partial thromboplastin time (PTT), International normalized ratio, IgA, Ca, P, Mg, Zinc, Cu and K. BMI was calculated from weight and height (kg/m^2^) and nutritional risk index (NRI) was calculated as: NRI = 1.519 \_ serum albumin (g/L) +41.7 \_ (current/usual body weight).\[[@ref20]\] Based on NRI, at risk for malnutrition was defined as NRI fewer than 83.5 and patients with a NRI \>97.5 were considered non-malnourished.

Montreal classification of severity of UC, which previously described\[[@ref21]\] was used for classification of UC at the time of enrollment. Due to lesser number of patients with severe UC, patients with moderate and severe UC were analyzed in the combination group compared to patients with mild UC.

All analysis was done by SPSS-20 and data are presented as means ± 1SD, median \[interquartile range\] or number (%) based on the variables. age, duration of disease, BMI and laboratory parameters between patients with mild or moderate to severe UC compared by Mann-Whitney test. Sex and the number of patients with abnormal laboratory parameters were compared by Chi-square test between patients regard to UC status. Relationship between patients' age, disease duration and laboratory parameters were assessed by Spearman\'s Correlation Coefficient. Statistical significance was accepted at *P* \< 0.05.

RESULTS {#sec1-3}
=======

Studied patients had the mean age of 38.3 ± 12.4. Fifty five patients (51.5%) were male and 48 patients (48.5%) were female. In total 99 patients were evaluated 12 patients had mild UC and 87 patients had moderate to severe UC. The comparison of age, sex, BMI and disease duration are shown in [Table 1](#T1){ref-type="table"}, stratified by UC status. Patients with mild UC were younger and more proportion of them were female than those with moderate to severe UC, also disease duration in patients with mild UC was longer than those with moderate to severe UC. However, these differences were not statistically significant (*P* \> 0.05).

###### 

Age, disease duration, BMI and sex in 99 patients with ulcerative colitis

![](ABR-3-58-g001)

According to the NRI, 90 patients (90.9%) were not malnourished and nine patients (9.1%) were at moderate to severe risk for malnutrition. Age and disease duration in patients at moderate to severe risk for malnutrition were higher than patients who were not malnourished. All patients at moderate to severe risk for malnutrition had moderate to severe UC, whereas, all patients with mild UC were not malnourished \[[Table 2](#T2){ref-type="table"}\] but statistical significant were not observed (*P* \> 0.05)

###### 

Association between nutritional risk index with patients' age, disease duration, and ulcerative colitis status
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In [Table 3](#T3){ref-type="table"}, results for comparison of laboratory parameters between patients with mild or moderate to severe UC are shown. As shown in the table, only, k in patients with moderate to severe UC was significantly higher than those with mild UC (*P* = 0.017). Other laboratory parameters were similar between patients stratified by UC status. The proportion of patients with laboratory parameters below or upper the reference values are shown in [Figure 1](#F1){ref-type="fig"}. Albumin, iron, folic acid, B12, vitamin D, PTT, P, Zinc and Cu defined as abnormal if these were below the reference values, and Hb, vitamin A, IgA, Ca, Mg and K defined as abnormal if these were greater than the reference values. The proportion of patients with abnormal laboratory parameters was not statistically significant between patients, stratified by UC status (*P* \> 0.05).

###### 

Comparison of laboratory parameters regard to patients ulcerative colitis status
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![The proportion of patients with laboratory parameters below or upper the reference values in 99 patients, stratified by ulcerative colitis status (*P* \> 0.05)](ABR-3-58-g004){#F1}

Relationship between patients' age and duration of disease with laboratory parameters are shown in [Table 4](#T4){ref-type="table"}. Based on results age was significantly correlate with vitamin D, IgA and K (*P* \> 0.05), also duration of disease was significantly correlate with *P* (*P* = 0.024) among laboratory parameters.

###### 

Correlation between patients' age and disease duration with laboratory parameters in 99 patients with ulcerative colitis
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DISCUSSION {#sec1-4}
==========

Results of the present study that aimed to investigate the nutritional status of UC patients in Isfahan, Iran, showed that in study population, most of the patients (88%) had moderate to severe UC. Patients with moderate to severe UC were older than the patients with mild UC. Duration of disease, BMI and laboratory parameters (except the value of serum potassium level) in patients with moderate to severe was similar to patients with mild UC. Value of serum potassium level in moderate to severe UC patients was significantly more than patients with mild UC (*P* value = 0.017). All 12 patients with mild UC had normal nutrition and were not at risk for malnourished, but 10% of patients moderate to severe UC, were at moderate to severe risk for malnourished. we find significant positive correlation between patients' age with the value of vitamin D, IgA and K, which means older patients, specially whom with moderate to severe UC, had higher value of serum vitamin D, IgA and K. Furthermore, positive correlation was found between duration of patients' disease with the value of P, whereas, increasing in duration of disease cause to increase in the level of P. The proportion of abnormal laboratory parameters in patients with moderate to severe UC was similar to patients with mild UC.

Previous studies showed that IBD affects equally both sexes and in the present study most of the patients were male (51%). However, previous studies by Rocha *et al*.,\[[@ref12]\] found that 40% out of IBD patients were male and Oliveira *et al*.,\[[@ref22]\] found that 37% out of UC patients were male.

In most of the previous studies, nutrition status was compared between UC patients with CD patients and healthy subjects. In Ghoshal *et al*.,\[[@ref23]\] study 62 patients with IBD (55 UC and seven CD patients) and 42 healthy subjects were evaluated for nutrition using dietary survey. Authors reported that protein, iron and BMI in IBD patients were lower among the IBD patients than among the healthy subjects. Patients with CD had a lower level of Hb and serum total protein compare to UC and CD patients and serum albumin, BMI, CA and iron were comparable between UC and CD patients. In the present study, CD patients and healthy subjects were not included, but in UC patients' protein, iron, BMI, Hb, serum albumin and CA in compare to the reference values were not statistically significant between patients, stratified by UC status.

Another study\[[@ref24]\] reported that, in 76 IBD and 30 healthy subjects, all investigated nutritional parameters except mean corpuscular volume (MCV), tryglicerides and serum total protein level were significantly different in UC and CD patients compared to control subjects also they found that serum albumin level and BMI were the most predictive parameters of malnutrition and concluded that these two parameters are simple and convenient methods for the assessment of the nutritional status in UC and CD patients. In our study, all laboratory parameters except k in UC patients were similar based on degree of disease severity but healthy subjects were not assessed in our study to compare with UC patients. Authors in Mijac *et al*.\[[@ref24]\] study, reported that in patients with active IBD, the prevalence of under nutrition was 25-69.7% and severe under nutrition was 1.3-31.6%. In the present study, 96 UC patients severe under nutrition have been detected in 9.1% of them.

Folic acid and vitamin B12 deficiencies due to malnutrition, malabsorption and anti-folate medications are quite common in UC and CD patients, and the deficiency of these key nutrients leads to increased homocysteine levels in UC and CD patients.\[[@ref20][@ref25][@ref26]\] It was showed that the value of folic acid in UC patients is lower than that of the healthy subjects,\[[@ref27]\] in our study the value of folic acid in UC patients was not compared with healthy subjects but we found that disease severity could not be affected on the value of folic acid in these patients. As said, it is known that, several factors in IBD patients include inadequate intake, increased consumption or folate malabsorption in patients using medications might be associated deficiency of folic acid.\[[@ref28]\] Furthermore, Akbulut *et al*.\[[@ref27]\] reported that vitamin B12 levels were found to have decreased in UC patients compared to control group; however, this findings did not attain statistical significance. Our finding showed in UC patients the mean of vitamin B12 levels similar to Akbulut *et al*.\[[@ref27]\] study.

Pappa *et al*.\[[@ref29]\] study identified vitamin D deficiency in 34.6% of children and young adults with IBD. Furthermore, other studies\[[@ref30]\] reported the prevalence of vitamin D deficiency lower than Pappa *et al*.\[[@ref29]\] study. In present study, vitamin D deficiency was observed in 87% of UC patients, which was higher than Pappa *et al*.\[[@ref29]\] and Sentongo *et al*.\[[@ref30]\] However, studied population in these studies included UC and CD patients.

In Nguyen *et al*.\[[@ref31]\] study, among IBD patients with malnutrition the crude mortality rate was significantly more than IBD patients who did not have malnutrition (2.7% vs. 0.5% respectively, *P* ≤ 0.0001). However, in this study, administrative data do not cover the clinical detail to adjust for IBD-specific disease severity and they could not assess the effect of combination of malnutrition and disease severity on mortality rate among in these patients. In the present study, malnutrition in UC patients was find regard to disease severity but we did not follow the patients and our data do not cover detail about rate of mortality among studied patients. Therefore, we were limited in how we could assess the risk of mortality based on degree of malnutrition and disease severity. Sample size may be to be another limitation of the present study, because of the small number of patients with mild UC can be cause of low power to detect small differences between patients with mild UC or moderate to severe UC regard to NRI status. Therefore, further studies with larger group of UC patients are and healthy subjects necessary to be done to compare nutrition status and laboratory parameters as risk factors and their association with mortality, morbidity and other variables in these patients based on degree of disease severity and in contrast to healthy subjects.

Overall, the results of this study revealed that in studied UC patients, risk for malnutrition was similar based on degree of disease severity. Patients with moderate to severe UC were at moderate to severe risk for malnutrition more than patients with mild UC. Furthermore, among laboratory parameters, only K maybe was defined as a marker in patients with moderate to severe UC compare to patients with mild UC, however, further studies are required to be done.
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